Image-guided therapy developer ViewRay has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its radiation therapy treatment planning and delivery software as a nonhuman use research system.
Currently in the late stages of development, the integrated ViewRay system combines simultaneous MRI and radiation therapy delivery. The company said it's working to secure FDA clearance to commercially distribute the system for clinical use.
